Back to Search
Start Over
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
- Source :
- Journal of the European Academy of Dermatology and Venereology, 34(9), 1900-1913. Wiley, Joly, P, Horvath, B, Patsatsi, Uzun, S, Bech, R, Beissert, S, Bergman, R, Bernard, P, Borradori, L, Caproni, M, Caux, F, Cianchini, G, Daneshpazhooh, M, De, D, Dmochowski, M, Drenovska, K, Ehrchen, J, Feliciani, C, Goebeler, M, Groves, R, Guenther, C, Hofmann, S, Ioannides, D, Kowalewski, C, Ludwig, R, Lim, Y L, Marinovic, B, Marzano, A V, Mascaró, J M, Mimouni, D, Murrell, D F, Pincelli, C, Squarcioni, C P, Sárdy, M, Setterfield, J, Sprecher, E, Vassileva, S, Wozniak, K, Yayli, S, Zambruno, G, Zillikens, D, Hertl, M & Schmidt, E 2020, ' Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) ', Journal of the European Academy of Dermatology and Venereology, vol. 34, no. 9, pp. 1900-1913 . https://doi.org/10.1111/jdv.16752, Joly, P, Horwath, B H, Patsatsi, K, Uzun, S, Bech, R, Beissert, S, Bergman, R, Bernard, P, Borradori, L, Caproni, M, Caux, F, Cianchini, G, Daneshpazhooh, M, Dipankar, D, Dmochowski, M, Drenovska, K, Ehrchen, J, Feliciani, C, Goebeler, M, Groves, R, Guenther, C, Hofmann, S, Ioannides, D, Kowalewski, C, Ludwig, R, Lim, Y L, Marinovic, B, Marzano, A V, Mascaró, J M, Mimouni, D, Murrel, D F, Pincelli, C, Squarcioni, C P, Sárdy, M, Setterfield, J, Sprecher, E, Vassileva, S, Wozniak, K, Yayli, S, Zambruno, G, Zillikens, D, Hertl, M & Schmid, E 2020, ' UPDATED S2K GUIDELINES ON THE MANAGEMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS INITIATED BY THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) ', Journal of the European Academy of Dermatology and Venereology : JEADV . https://doi.org/10.1111/jdv.16752
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Background: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost always fatal. Due to its rarity, only few randomized controlled therapeutic trials are available. Recently, rituximab has been approved as first-line treatment for moderate and severe pemphigus vulgaris in Europe and the USA.Objectives: The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) has initiated a throughout update of the guideline for the management of patients with pemphigus. Results: The guidelines for the management of pemphigus were updated and the degree of consent among all task force members was included. The final version of the guideline was consented by the European Dermatology Forum (EDF) and several patient organisations.
- Subjects :
- medicine.medical_specialty
Venereology
AZATHIOPRINE
MULTICENTER
Dermatology
THERAPY
030207 dermatology & venereal diseases
03 medical and health sciences
DOUBLE-BLIND
0302 clinical medicine
IMMUNOADSORPTION
immune system diseases
medicine
RITUXIMAB
education
pemphigus vulgaris, pemphigus foliates, guidelines, management
skin and connective tissue diseases
610 Medicine & health
COMBINATION
MYCOPHENOLATE-MOFETIL
Pemphigus foliaceus
education.field_of_study
integumentary system
business.industry
Pemphigus vulgaris
AUTOIMMUNE BULLOUS DISEASE
Guideline
DESMOGLEIN 1
medicine.disease
Pemphigus
Infectious Diseases
Desmoglein 1
030220 oncology & carcinogenesis
Desmoglein 3
Rituximab
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 14683083 and 09269959
- Volume :
- 34
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- Journal of the European Academy of Dermatology and Venereology
- Accession number :
- edsair.doi.dedup.....4770dfe8d52ba91dbbfcf42754b548ed